Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases

NCT01151644 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT01151644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01151644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases
Lead sponsor
University of Sao Paulo
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2010
Completion date
December 31, 2010
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid syndrome, dermatomyositis (dm), dmixed connective tissue disease, juvenile dm, juvenile idiopathic arthritis, juvenile sle, rheumatoid arthritis, sjögren's syndrome, spondyloarthritis, systemic lupus erythematosus (sle), systemic sclerosis (ssc), systemic vasculitis